Weijia Duan

Non-<i>HFE</i> mutations in haemochromatosis in China: combination of heterozygous mutations involving <i>HJV</i> signal peptide variants

Tingxia Lv, Wei Zhang, Anjian Xu et al. · Journal of Medical Genetics · 2018 · 37 citations

Life Sciences, Genetics, Molecular Genetics +15

Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis

Qianyi Wang, Hong You, Xiaojuan Ou et al. · Hepatology International · 2019 · 36 citations · Full text

Medicine, Pathobiology, Pathology +16

A novel <i>SLC40A1</i> p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China

Wei Zhang, Anjian Xu, Yanmeng Li et al. · Liver International · 2018 · 35 citations

Medicine, Genetics, Molecular Genetics +16

Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA

Weijia Duan, Xiaojuan Ou, Xiaoming Wang et al. · Revista Española de Enfermedades Digestivas · 2018 · 29 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Mutation analysis of the ABCC2 gene in Chinese patients with Dubin‑Johnson syndrome

Lina Wu, Wei Zhang, Siyu Jia et al. · Experimental and Therapeutic Medicine · 2018 · 25 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12